MariTide is a once-monthly GLP-1 that does more than curb appetite—it blocks GIP, a hormone linked to fat storage and insulin resistance. In a Phase 2 trial with 592 adults, it led to up to 20% weight loss, lower A1C, and better fat reduction—especially with slow dose escalation.
Learn what sets MariTide apart, who it might work for, and how it compares to meds like Wegovy and Zepbound.
Orforglipron is a once-daily oral GLP-1 medication showing powerful results for people with type 2 diabetes. It lowers A1C and supports significant weight loss—all without injections, food restrictions, or lifestyle coaching. Based on the ACHIEVE-1 trial, this treatment could change how early type 2 diabetes is managed.
If walking causes burning or cramping in your legs, it could be more than just aging or being out of shape—it might be Peripheral Artery Disease (PAD). Learn how semaglutide, commonly known for weight loss and diabetes, is now showing promise in improving mobility and reducing leg pain by improving blood flow.
CagriSema and Tirzepatide are two of the most talked-about names in obesity treatment—now see how they compare. Explore the latest clinical results, real-world impacts, and what sets each medication apart when it comes to weight loss and metabolic health.
Mazdutide is a new GLP-1/glucagon receptor agonist from China, showing promising weight loss results in recent trials. With up to 14% reduction in a lower-BMI population, it raises key questions about how it compares to Wegovy, Zepbound, and the future of obesity treatment.
On GLP-1s like Ozempic or Wegovy, food can start to feel dull—it’s not just you. I explain why this happens and what it means for your brain, cravings, and nutrition. If meals feel joyless, there are ways to bring satisfaction and balance back.
Creatine is one of the most studied and effective supplements—yet still misunderstood. I’m breaking down what it does, how it supports strength, brain function, and recovery, and why it’s not just for athletes. Clear, science-backed, and myth-free.
Struggling with shame or judgment around weight-loss medications like Wegovy, Ozempic, or Zepbound? You’re not alone. I’m exploring the stigma, internalized guilt, and societal pressure that lead many people to hide their GLP-1 medications. Learn why obesity treatment is misunderstood, why it’s not the “easy way out,” and how to reclaim your health without apology.
Survodutide is one of the most promising new weight-loss medications, combining GLP-1 and glucagon in a way we haven’t seen before. I break down how it works, what the early data shows, and why it could be a game-changer for both obesity and liver health.
I break down the SURMOUNT-5 trial comparing Zepbound (tirzepatide) and Wegovy (semaglutide) for weight loss. I cover the real numbers, side effects, and what this means for obesity treatment. These results could shift how we think about first-line options for chronic weight management.
Calculate your daily calorie and protein targets to help you achieve your weight goals.
Calculate your daily calorie and protein targets to help you achieve your weight goals.
